HUM vs LUNG · P/E 39, rev $117.76B vs rev $83.8M
Humana Inc (HUM) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the HUM and LUNG stock pages for the full models.
Not investment advice.